BRIEF-China Resources Pharmaceutical Posts HY Results For KPC Pharmaceuticals
Reuters
Aug 15
BRIEF-China Resources Pharmaceutical Posts HY Results For KPC Pharmaceuticals
Aug 15 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:
HY NET PROFIT ATTRIBUTABLE FOR KPC PHARMACEUTICALS RMB198.4 MILLION
HY REVENUE FOR KPC PHARMACEUTICALS RMB3.35 BILLION
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.